Complement receptor type 2 (CR2) is an important receptor for primary infection of EBV in B cells and epithelial cells [37]; however, we found it to be downregulated in NPC, which suggests a different manner in which EBV can affect NPC. The gene discussed is CR2; the disease is nasopharyngeal carcinoma.